Current Report Filing (8-k)
June 10 2019 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported):
June 7, 2019
APOLLO
MEDICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified
in Charter)
Delaware
|
|
001-37392
|
|
95-4472349
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
1668 S. Garfield Avenue, 2nd Floor, Alhambra,
CA 91801
(Address of Principal Executive Offices,
and Zip Code)
(626) 282-0288
Registrant’s Telephone Number,
Including Area Code
|
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
|
¨
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
AMEH
|
Nasdaq Capital Market
|
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 1.01 Entry into a Material Definitive Agreement.
On or about June 7, 2019, Apollo Medical
Holdings, Inc., entered into Amendments to the Lock-Up Agreements (“Lock-Up Amendments”) to amend the Lock-Up Agreements
it entered into with certain former Network Medical Management, Inc. (“NMM”) shareholders on or about December 8, 2017.
Under the Lock-Up Amendments, shareholders representing over 90% of the total shares of common stock held by former NMM shareholders
have agreed to extend the June 7, 2019 expiration date of the “First Lock-Up Period” (as defined in the Lock-Up Agreements)
to September 30, 2019. Except as described above, all the terms and conditions of the Lock-Up Agreements remain unchanged and in
full force and effect.
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
APOLLO MEDICAL HOLDINGS, INC.
|
|
|
Dated: June 10, 2019
|
By:
|
/s/ Thomas S. Lam, M.D
|
|
Name:
|
Thomas S. Lam, M.D
|
|
Title:
|
Chief Executive Officer
|
Apollo Medical (NASDAQ:AMEH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Apollo Medical (NASDAQ:AMEH)
Historical Stock Chart
From Sep 2023 to Sep 2024